Replimune Group, Inc. Competitors
Symbol | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
---|---|---|---|---|---|
![]() ASND
Ascendis Pharma A/S |
$140.28 | $7.77 B | -14.19 | 1017 | $363.64 M |
![]() AVTE
Aerovate Therapeutics, Inc. |
$2.70 | $597.48 M | -6.84 | 30 | $0 |
![]() CERE
Cerevel Therapeutics Holdings, Inc. |
$44.96 | $7.29 B | -14.66 | 355 | $0 |
![]() CRNX
Crinetics Pharmaceuticals, Inc. |
$50.49 | $3.53 B | -11.86 | 437 | $1.04 M |
![]() GOSS
Gossamer Bio, Inc. |
$1.09 | $124.06 M | -0.65 | 135 | $0 |
![]() KRON
Kronos Bio, Inc. |
$0.97 | $44.62 M | -0.37 | 62 | $6.29 M |
![]() KROS
Keros Therapeutics, Inc. |
$15.64 | $1.76 B | -9.45 | 169 | $3.55 M |
![]() KURA
Kura Oncology, Inc. |
$8.51 | $1.66 B | -10.03 | 192 | $53.88 M |
![]() LYRA
Lyra Therapeutics, Inc. |
$0.22 | $19.53 M | -0.27 | 88 | $1.53 M |
![]() MLYS
Mineralys Therapeutics, Inc. |
$13.05 | $652.38 M | -6.03 | 51 | $0 |
![]() MRUS
Merus N.V. |
$42.39 | $3.50 B | -19.38 | 260 | $36.13 M |
![]() NAMS
NewAmsterdam Pharma Company N.V. |
$25.85 | $1.74 B | -7.15 | 68 | $45.56 M |
![]() NUVL
Nuvalent, Inc. |
$78.09 | $5.11 B | -32.72 | 142 | $0 |
![]() NVCT
Nuvectis Pharma, Inc. |
$6.61 | $116.38 M | -4.5 | 13 | $0 |
![]() PRTC
PureTech Health plc |
$18.69 | $809.08 M | -12.47 | 90 | $3.33 M |
![]() PTGX
Protagonist Therapeutics, Inc. |
$38.09 | $2.04 B | 13.7 | 126 | $434.43 M |
![]() SNDX
Syndax Pharmaceuticals, Inc. |
$13.69 | $1.66 B | -6.02 | 270 | $23.68 M |
![]() UTHR
United Therapeutics Corporation |
$355.39 | $12.20 B | 13.02 | 1305 | $2.88 B |
![]() VTYX
Ventyx Biosciences, Inc. |
$2.42 | $229.83 M | -1.01 | 79 | $0 |